OrthoPediatrics Corp (NASDAQ: KIDS) saw its stock soar by 5.29% in the intraday trading session on Wednesday, driven by positive analyst actions and strong financial performance reported by the company.
On the analyst front, Truist Securities adjusted its price target for KIDS to $26 from $25, maintaining a Hold rating. Meanwhile, Needham maintained its bullish stance, keeping its price target at $42 per share for the pediatric orthopedics company.
The company itself provided ample reasons for investors to be optimistic about its prospects. In its recent earnings report, OrthoPediatrics announced a record 40% increase in total revenue for the fourth quarter of 2024, reaching $52.7 million. This impressive growth was fueled by strong performances across its trauma, deformity, and scoliosis segments.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.